Protein C Deficiency
Edit

Protein C deficiency is a disorder that increases the risk of developing abnormal blood clots; the condition can be mild or severe.

genetic conditions

1. Introduction

Individuals with mild protein C deficiency are at risk of a type of blood clot known as a deep vein thrombosis (DVT). These clots occur in the deep veins of the arms or legs, away from the surface of the skin. A DVT can travel through the bloodstream and lodge in the lungs, causing a life-threatening blockage of blood flow known as a pulmonary embolism (PE). While most people with mild protein C deficiency never develop abnormal blood clots, certain factors can add to the risk of their development. These factors include increased age, surgery, inactivity, or pregnancy. Having another inherited disorder of blood clotting in addition to protein C deficiency can also influence the risk of abnormal blood clotting.

In severe cases of protein C deficiency, infants develop a life-threatening blood clotting disorder called purpura fulminans soon after birth. Purpura fulminans is characterized by the formation of blood clots in the small blood vessels throughout the body. These blood clots block normal blood flow and can lead to localized death of body tissue (necrosis). Widespread blood clotting uses up all available blood clotting proteins. As a result, abnormal bleeding occurs in various parts of the body, which can cause large, purple patches on the skin. Individuals who survive the newborn period may experience recurrent episodes of purpura fulminans.

2. Frequency

Mild protein C deficiency affects approximately 1 in 500 individuals. Severe protein C deficiency is rare and occurs in an estimated 1 in 4 million newborns.

3. Causes

Protein C deficiency is caused by mutations in the PROC gene. This gene provides instructions for making protein C, which is found in the bloodstream and is important for controlling blood clotting. Protein C blocks the activity of (inactivates) certain proteins that promote blood clotting.

Most of the mutations that cause protein C deficiency change single protein building blocks (amino acids) in protein C, which disrupts its ability to control blood clotting. Individuals with this condition do not have enough functional protein C to inactivate clotting proteins, which results in the increased risk of developing abnormal blood clots. Protein C deficiency can be divided into type I and type II based on how mutations in the PROC gene affect protein C. Type I is caused by PROC gene mutations that result in reduced levels of protein C, while type II is caused by PROC gene mutations that result in the production of an altered protein C with reduced activity. Both types of mutations can be associated with mild or severe protein C deficiency; the severity is determined by the number of PROC gene mutations an individual has.

4. Inheritance

Protein C deficiency is inherited in an autosomal dominant pattern, which means one altered copy of the PROC gene in each cell is sufficient to cause mild protein C deficiency. Individuals who inherit two altered copies of this gene in each cell have severe protein C deficiency.

5. Other Names for This Condition

  • hereditary thrombophilia due to protein C deficiency
  • PROC deficiency

References

  1. Brouwer JL, Lijfering WM, Ten Kate MK, Kluin-Nelemans HC, Veeger NJ, van derMeer J. High long-term absolute risk of recurrent venous thromboembolism inpatients with hereditary deficiencies of protein S, protein C or antithrombin.Thromb Haemost. 2009 Jan;101(1):93-9.
  2. Cafolla A, D'Andrea G, Baldacci E, Margaglione M, Mazzucconi MG, Foà R.Hereditary protein C deficiency and thrombosis risk: genotype and phenotyperelation in a large Italian family. Eur J Haematol. 2012 Apr;88(4):336-9. doi:10.1111/j.1600-0609.2011.01742.x.
  3. Goldenberg NA, Manco-Johnson MJ. Protein C deficiency. Haemophilia. 2008Nov;14(6):1214-21. doi: 10.1111/j.1365-2516.2008.01838.x.
  4. Knoebl PN. Severe congenital protein C deficiency: the use of protein Cconcentrates (human) as replacement therapy for life-threatening blood-clottingcomplications. Biologics. 2008 Jun;2(2):285-96.
  5. Mahmoodi BK, Brouwer JL, Ten Kate MK, Lijfering WM, Veeger NJ, Mulder AB,Kluin-Nelemans HC, Van Der Meer J. A prospective cohort study on the absoluterisks of venous thromboembolism and predictive value of screening asymptomaticrelatives of patients with hereditary deficiencies of protein S, protein C orantithrombin. J Thromb Haemost. 2010 Jun;8(6):1193-200. doi:10.1111/j.1538-7836.2010.03840.x.
More
Related Content
This entry reviews the health condition known as Roemheld syndrome, or gastrocardiac syndrome in modern medicine. A pathology of gastrointestinal origin, the syndrome relies on a gut–brain–heart triad, interconnected by the vagus nerve. Pressure from the intestines pushes the stomach into the diaphragm and activates the vagus nerve, which affects the heart rate and gives the perception of cardiac issues. This distressing sensation, which usually comes after meals or with other digestive problems, causes anxiety or panic. Although events not arising from anatomic abnormalities are relatively harmless, hypersensitivity to these uncomfortable sensations may precipitate psychiatric problems (anxiety or depression) that cause repeated gastrocardiac events through sympathetic activation and the disruption of peristalsis. Treatment is usually symptomatic and may include diet, lifestyle changes, probiotics, or prescriptions that increase gut motility, but this specific set of reproducible symptoms may also be caused by hiatal hernia or side effects from medication/surgery and treated with respect to those mechanical causes. This review highlights details from the most current knowledge of the condition and offers suggestions for clinical management based on the literature.
Keywords: Roemheld; gastrocardiac; IBS; SIBO; vagus
Growing older is inevitable, but does it have to mean losing your vitality? The secret to aging healthily, strongly, and gracefully is waiting to be uncovered. As one of the essential nutrients for humans, protein plays a crucial role in boosting immunity and is key in fighting viral infections! It also helps maintain muscle, bone, and nerve stability while promoting metabolism and cardiovascular health. Which type of protein is best for longevity? Researchers from Harvard University published a paper in The American Journal of Clinical Nutrition found that higher intake of plant protein is linked to a longer, healthier life. For every 3% increase in energy intake from plant protein, the chances of healthy aging rise by a remarkable 46%. In contrast, with animal protein, every 3% increase in energy intake lowers the chances of healthy aging by 6%. And just adding 10 grams of plant protein each day boosts your odds of healthy aging by 35%. Research shows that plant-based foods help lower bad cholesterol levels, giving your blood vessels a much-needed 'spring cleaning'. This reduces cholesterol buildup on vessel walls and helps prevent atherosclerosis. At the same time, it helps lower blood pressure and improve insulin sensitivity, playing a crucial role in maintaining cardiovascular stability and balancing blood sugar levels. Additionally, plant protein can lower levels of pro-inflammatory markers, reducing inflammation in our body's vast and complex 'ecosystem'. These mechanisms work together like a finely tuned health machine, giving those who consume more plant protein a stronger resistance against the threats of chronic diseases. Studies have also found that plant protein can significantly reduce the risk of cognitive and mental health decline.
Keywords: healthy aging; diet; protein; animal protein; plant protein; lifestyle
In this video, we get to understand how pathological changes are reflected in clinical signs.
Keywords: Amoebiasis; Dysentery; Entamoeba histolytica; Protozoan infections; Pathology; Clinical presentation
The human gut is a complex ecosystem that supports billions of living species, including bacteria, viruses, archaea, phages, fungi, and unicellular eukaryotes. Bacteria give genes and enzymes for microbial and host-produced compounds, establishing a symbiotic link between the external environment and the host at both the gut and systemic levels. The gut microbiome, which is primarily made up of commensal bacteria, is critical for maintaining the healthy host’s immune system, aiding digestion, synthesizing essential nutrients, and protecting against pathogenic bacteria, as well as influencing endocrine, neural, humoral, and immunological functions and metabolic pathways. Qualitative, quantitative, and/or topographic shifts can alter the gut microbiome, resulting in dysbiosis and microbial dysfunction, which can contribute to a variety of noncommunicable illnesses, including hypertension, cardiovascular disease, obesity, diabetes, inflammatory bowel disease, cancer, and irritable bowel syndrome. While most evidence to date is observational and does not establish direct causation, ongoing clinical trials and advanced genomic techniques are steadily enhancing our understanding of these intricate interactions. This video will explore key aspects of the relationship between gut microbiota, eubiosis, and dysbiosis in human health and disease, highlighting emerging strategies for microbiome engineering as potential therapeutic approaches for various conditions.
Keywords: gut barrier; gut microbes; intestinal permeability; leaky gut; microbiome
Gallionella Image
Gallionella, iron bacterium. The bacterium creates a filament which adheres to surfaces. Many filaments may form aggregates. The mucus secretions become brown, thicker and more brittle with age.
Keywords: bacteria; Gallionella
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 521
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020
Video Production Service